Skip to main content

Articles

Page 116 of 154

  1. Antibodies to citrullinated proteins (anti-cyclic-citrullinated peptide [anti-CCP] antibodies) are highly specific for rheumatoid arthritis (RA) and precede the onset of disease symptoms, indicating a pathogen...

    Authors: Annette HM van der Helm-van Mil, Kirsten N Verpoort, Ferdinand C Breedveld, René EM Toes and Tom WJ Huizinga
    Citation: Arthritis Research & Therapy 2005 7:R949

    The Editorial to this article has been published in Arthritis Research & Therapy 2019 21:227

  2. When purified under rigorous conditions, some murine anti-double-stranded-DNA (anti-dsDNA) antibodies actually bind chromatin rather than dsDNA. This suggests that they may actually be antinucleosome antibodie...

    Authors: Lesley J Mason, Anastasia Lambrianides, Joanna D Haley, Jessica J Manson, David S Latchman, David A Isenberg and Anisur Rahman
    Citation: Arthritis Research & Therapy 2005 7:R971
  3. In synovial cells of patients with osteoarthritis (OA) and rheumatoid arthritis (RA), conversion products of major anti-inflammatory androgens are as yet unknown but may be proinflammatory. Therefore, therapy ...

    Authors: Martin Schmidt, Claudia Weidler, Heidrun Naumann, Sven Anders, Jürgen Schölmerich and Rainer H Straub
    Citation: Arthritis Research & Therapy 2005 7:R938
  4. Models of rheumatoid arthritis (RA) in laboratory animals are important tools for research into pathogenic mechanisms and the development of effective, safe therapies. Rodent models (rats and mice) have provid...

    Authors: Michel PM Vierboom, Margreet Jonker, Ronald E Bontrop and Bert 't Hart
    Citation: Arthritis Research & Therapy 2005 7:145
  5. Certain monoclonal antibodies (mAbs) to type II collagen (CII) induce arthritis in vivo after passive transfer and have adverse effects on chondrocyte cultures and inhibit self assembly of collagen fibrils in vit...

    Authors: Duncan E Crombie, Muhammed Turer, Beltzane Biurrun Zuasti, Bayden Wood, Don McNaughton, Kutty Selva Nandakumar, Rikard Holmdahl, Marie-Paule Van Damme and Merrill J Rowley
    Citation: Arthritis Research & Therapy 2005 7:R927
  6. The receptor for advanced glycation endproducts (RAGE) interacts with distinct ligand families linked to the inflammatory response. Studies in animal models suggest that RAGE is upregulated in the inflamed joi...

    Authors: Bernhard Moser, Barry I Hudson and Ann Marie Schmidt
    Citation: Arthritis Research & Therapy 2005 7:142
  7. Basic calcium phosphate (BCP) crystals, including hydroxyapatite, octacalcium phosphate (OCP) and carbonate-apatite, have been associated with severe osteoarthritis and several degenerative arthropathies. Most...

    Authors: Hang-Korng Ea, Benjamin Uzan, Christian Rey and Frédéric Lioté
    Citation: Arthritis Research & Therapy 2005 7:R915
  8. Transcription factor hypoxia-inducible factor (HIF)-1 protein accumulates and activates the transcription of genes that are of fundamental importance for oxygen homeostasis – including genes involved in energy...

    Authors: Kazuo Yudoh, Hiroshi Nakamura, Kayo Masuko-Hongo, Tomohiro Kato and Kusuki Nishioka
    Citation: Arthritis Research & Therapy 2005 7:R904

    The Erratum to this article has been published in Arthritis Research & Therapy 2005 7:225

  9. Spondyloarthropathies are inflammatory diseases closely associated with human leukocyte antigen (HLA)-B27 by unknown mechanisms. One of these diseases is reactive arthritis (ReA), which is typically triggered ...

    Authors: Sanna Vähämiko, Markus A Penttinen and Kaisa Granfors
    Citation: Arthritis Research & Therapy 2005 7:136
  10. Anti-endothelial-cell antibodies are associated with psychiatric manifestations in systemic lupus erythematosus (SLE). Our primary aim in this study was to seek and characterize molecules that behave as endoth...

    Authors: Paola Margutti, Maurizio Sorice, Fabrizio Conti, Federica Delunardo, Mauro Racaniello, Cristiano Alessandri, Alessandra Siracusano, Rachele Riganò, Elisabetta Profumo, Guido Valesini and Elena Ortona
    Citation: Arthritis Research & Therapy 2005 7:R896
  11. In previous studies we have found that FcγRI determines chondrocyte death and matrix metalloproteinase (MMP)-mediated cartilage destruction during IFN-γ-regulated immune complex arthritis (ICA). Binding of imm...

    Authors: Peter LEM van Lent, Karin CAM Nabbe, Arjen B Blom, Annet Sloetjes, Astrid EM Holthuysen, Jay Kolls, Fons AJ Van De Loo, Steven M Holland and Wim B Van Den Berg
    Citation: Arthritis Research & Therapy 2005 7:R885
  12. Collagen-induced arthritis (CIA), an approved animal model for rheumatoid arthritis, is thought to be a T cell-dependent disease. There is evidence that CD8+ T cells are a major subset controlling the pathogenesi...

    Authors: Kristin Bauer, Annika Knipper, Hoang Tu-Rapp, Dirk Koczan, Hans-Jürgen Kreutzer, Horst Nizze, Eilhard Mix, Hans-Juergen Thiesen, Rikard Holmdahl and Saleh M Ibrahim
    Citation: Arthritis Research & Therapy 2005 7:R877
  13. Although the precise pathogenesis of rheumatoid arthritis (RA) remains unclear, many cell populations, including monocytes, macrophages, endothelial cells, fibroblasts and B cells, participate in the inflammat...

    Authors: Edward Keystone
    Citation: Arthritis Research & Therapy 2005 7(Suppl 3):S13

    This article is part of a Supplement: Volume 7 Supplement 3

  14. In rheumatoid arthritis, T cells, B cells, macrophages, and dendritic cells invade the synovial membranes, establishing complex microstructures that promote inflammatory/tissue destructive lesions. B cell invo...

    Authors: Cornelia M Weyand, Thorsten M Seyler and Jörg J Goronzy
    Citation: Arthritis Research & Therapy 2005 7(Suppl 3):S9

    This article is part of a Supplement: Volume 7 Supplement 3

  15. Until the pathophysiology/etiology of rheumatoid arthritis (RA) is better understood, treatment strategies must focus on disease management. Early diagnosis and treatment with disease-modifying antirheumatic d...

    Authors: Larry Moreland
    Citation: Arthritis Research & Therapy 2005 7(Suppl 3):S2

    This article is part of a Supplement: Volume 7 Supplement 3

  16. A better understanding of the initial mechanisms that lead to arthritic disease could facilitate development of improved therapeutic strategies. We characterized the synovial microcirculation of knee joints in...

    Authors: Philip Gierer, Saleh Ibrahim, Thomas Mittlmeier, Dirk Koczan, Steffen Moeller, Jürgen Landes, Georg Gradl and Brigitte Vollmar
    Citation: Arthritis Research & Therapy 2005 7:R868
  17. Analysis of biomarkers in synovial tissue is increasingly used in the evaluation of new targeted therapies for patients with rheumatoid arthritis (RA). This study determined the intrarater and inter-rater reli...

    Authors: Jasper J Haringman, Marjolein Vinkenoog, Danielle M Gerlag, Tom JM Smeets, Aeilko H Zwinderman and Paul P Tak
    Citation: Arthritis Research & Therapy 2005 7:R862
  18. Osteoarthritis (OA), the commonest form of arthritis and a major cause of morbidity, is characterized by progressive degeneration of the articular cartilage. Along with increased production and activation of d...

    Authors: Allan A Young, Margaret M Smith, Susan M Smith, Martin A Cake, Peter Ghosh, Richard A Read, James Melrose, David H Sonnabend, Peter J Roughley and Christopher B Little
    Citation: Arthritis Research & Therapy 2005 7:R852
  19. Somatic mutations have a role in the pathogenesis of a number of diseases, particularly cancers. Here we present data supporting a role of mitochondrial somatic mutations in an autoimmune disease, rheumatoid a...

    Authors: Tanya R Da Sylva, Alison Connor, Yvonne Mburu, Edward Keystone and Gillian E Wu
    Citation: Arthritis Research & Therapy 2005 7:R844
  20. Generalized osteoporosis in postmenopausal rheumatoid arthritis (RA) is caused both by estrogen deficiency and by the inflammatory disease. The relative importance of each of these factors is unknown. The aim ...

    Authors: Caroline Jochems, Ulrika Islander, Malin Erlandsson, Margareta Verdrengh, Claes Ohlsson and Hans Carlsten
    Citation: Arthritis Research & Therapy 2005 7:R837
  21. The disease category of early rheumatoid arthritis (RA) has been limited with respect to clinical criteria. Pathological manifestations of synovitis in patients whose disease is clinically classified as early ...

    Authors: Takahito Tsubaki, Norimasa Arita, Takuma Kawakami, Takayuki Shiratsuchi, Haruyasu Yamamoto, Nobuo Takubo, Kazuhito Yamada, Sanpei Nakata, Sumiki Yamamoto and Masato Nose
    Citation: Arthritis Research & Therapy 2005 7:R825
  22. The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily being expressed as a cell surface molecule and binding a variety of ligands. One of these ligands is high-m...

    Authors: Rille Pullerits, Maria Bokarewa, Leif Dahlberg and Andrej Tarkowski
    Citation: Arthritis Research & Therapy 2005 7:R817
  23. Therapies directed against tumour necrosis factor (TNF) are effective for the treatment of rheumatoid arthritis and reduce pain scores in this condition. In this study, we sought to explore mechanisms by which...

    Authors: Julia J Inglis, Ahuva Nissim, Delphine M Lees, Stephen P Hunt, Yuti Chernajovsky and Bruce L Kidd
    Citation: Arthritis Research & Therapy 2005 7:R807
  24. Blocking tumor necrosis factor-α either with monoclonal antibodies or with soluble receptor constructs has been proven to be effective with an acceptable safety profile in patients with rheumatoid arthritis, a...

    Authors: Filip Van den Bosch, Filip De Keyser, Herman Mielants and Eric M Veys
    Citation: Arthritis Research & Therapy 2005 7:121
  25. Frequent assessments of rheumatoid arthritis (RA) disease activity allow timely adaptation of therapy, which is essential in preventing disease progression. However, values of acute phase reactants (APRs) are ...

    Authors: Daniel Aletaha, Valerie PK Nell, Tanja Stamm, Martin Uffmann, Stephan Pflugbeil, Klaus Machold and Josef S Smolen
    Citation: Arthritis Research & Therapy 2005 7:R796
  26. Pathological processes involved in the initiation of rheumatoid synovitis remain unclear. We undertook the present study to identify immune and stromal processes that are present soon after the clinical onset ...

    Authors: Karim Raza, Francesco Falciani, S John Curnow, Emma J Ross, Chi-Yeung Lee, Arne N Akbar, Janet M Lord, Caroline Gordon, Christopher D Buckley and Mike Salmon
    Citation: Arthritis Research & Therapy 2005 7:R784

    The Editorial to this article has been published in Arthritis Research & Therapy 2019 21:226

  27. Interleukin-1 (IL-1), IL-17 and tumor necrosis factor alpha (TNF-α) are the main proinflammatory cytokines implicated in cartilage breakdown by matrix metalloproteinase (MMPs) in arthritic joints. We studied t...

    Authors: Abdelhamid Liacini, Judith Sylvester, Wen Qing Li and Muhammad Zafarullah
    Citation: Arthritis Research & Therapy 2005 7:R777
  28. The human leukocyte antigen B27 (HLA-B27) transgenic rat is a model of human inflammatory bowel disease, rheumatoid arthritis and psoriasis. Studies of chronic inflammation in other rat models have demonstrate...

    Authors: James C Keith Jr, Irma M Sainz, Irma Isordia-Salas, Robin A Pixley, Yelena Leathurby, Leo M Albert and Robert W Colman
    Citation: Arthritis Research & Therapy 2005 7:R769
  29. Hyaluronan (HA), an important component of connective tissues, is highly metabolically active, but the mechanisms involved in its catabolism are still largely unknown. We hypothesized that a protein similar to...

    Authors: Hafida El Hajjaji, Ada Asbury Cole and Daniel-Henri Manicourt
    Citation: Arthritis Research & Therapy 2005 7:R756
  30. Systemic-onset juvenile idiopathic arthritis (SJIA) is a disease of unknown etiology with an unpredictable response to treatment. We examined two groups of patients to determine whether there are serum protein...

    Authors: Takako Miyamae, David E Malehorn, Bonnie Lemster, Masaaki Mori, Tomoyuki Imagawa, Shumpei Yokota, William L Bigbee, Manda Welsh, Klaus Klarskov, Norihiro Nishomoto, Abbe N Vallejo and Raphael Hirsch
    Citation: Arthritis Research & Therapy 2005 7:R746
  31. Various dermatological conditions have been reported during tumor necrosis factor (TNF)-α-blocking therapy, but until now no prospective studies have been focused on this aspect. The present study was set up t...

    Authors: Marcel Flendrie, Wynand HPM Vissers, Marjonne CW Creemers, Elke MGJ de Jong, Peter CM van de Kerkhof and Piet LCM van Riel
    Citation: Arthritis Research & Therapy 2005 7:R666
  32. In this study, we investigated the hypotheses that in human intervertebral disc (IVD) degeneration there is local production of the cytokine IL-1, and that this locally produced cytokine can induce the cellula...

    Authors: Christine Lyn Le Maitre, Anthony J Freemont and Judith Alison Hoyland
    Citation: Arthritis Research & Therapy 2005 7:R732
  33. This dynamic magnetic resonance imaging (MRI) study is concerned with a prospective evaluation of wrist synovitis in patients with psoriatic arthritis (PsA) in comparison with patients with rheumatoid arthriti...

    Authors: Marco A Cimmino, Massimiliano Parodi, Stefania Innocenti, Giulia Succio, Simone Banderali, Enzo Silvestri and Giacomo Garlaschi
    Citation: Arthritis Research & Therapy 2005 7:R725
  34. B-cell depletive therapies have beneficial effects in patients suffering from rheumatoid arthritis. Nevertheless, the role of B cells in the pathogenesis of the disease is not clear. In particular, it is not k...

    Authors: Anne-Sophie Rouzière, Christian Kneitz, Arumugam Palanichamy, Thomas Dörner and Hans-Peter Tony
    Citation: Arthritis Research & Therapy 2005 7:R714
  35. Anti-PM/Scl antibodies represent a specific serological marker for a subset of patients with scleroderma (Scl) and polymyositis (PM), and especially with the PM/Scl overlap syndrome (PM/Scl). Anti-PM/Scl react...

    Authors: Michael Mahler, Reinout Raijmakers, Cornelia Dähnrich, Martin Blüthner and Marvin J Fritzler
    Citation: Arthritis Research & Therapy 2005 7:R704
  36. Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis (RA), exhibits anti-inflammatory, antiproliferative and immunosuppressive effects. Although most of the ...

    Authors: Bernhard M Kirsch, Maximilian Zeyda, Karl Stuhlmeier, Johannes Grisar, Josef S Smolen, Bruno Watschinger, Thomas M Stulnig, Walter H Hörl, Gerhard J Zlabinger and Marcus D Säemann
    Citation: Arthritis Research & Therapy 2005 7:R694
  37. Bone is integral to the pathogenesis of osteoarthritis (OA). Whether the bone area of the tibial plateau changes over time in subjects with knee OA is unknown. We performed a cohort study to describe this and ...

    Authors: Yuanyuan Wang, Anita E Wluka and Flavia M Cicuttini
    Citation: Arthritis Research & Therapy 2005 7:R687
  38. To assess the potential use of hyaluronic acid (HA) as adjuvant therapy in rheumatoid arthritis, the anti-inflammatory and chondroprotective effects of HA were analysed in experimental rat antigen-induced arth...

    Authors: Andreas Roth, Jürgen Mollenhauer, Andreas Wagner, Reneè Fuhrmann, Albrecht Straub, Rudolf A Venbrocks, Peter Petrow, Rolf Bräuer, Harald Schubert, Jörg Ozegowski, Gundela Peschel, Peter J Müller and Raimund W Kinne
    Citation: Arthritis Research & Therapy 2005 7:R677
  39. Immune and inflammatory systems are controlled by multiple cytokines, including interleukins and interferons. Many of these cytokines exert their biological functions through JAKs (Janus tyrosine kinases) and ...

    Authors: Akihiko Yoshimura, Hitomi Nishinakamura, Yumiko Matsumura and Toshikatsu Hanada
    Citation: Arthritis Research & Therapy 2005 7:100
  40. The objective was to improve understanding of adverse events occurring with celecoxib in the treatment of osteoarthritis and rheumatoid arthritis. Data were extracted from company clinical trial reports of ran...

    Authors: R Andrew Moore, Sheena Derry, Geoffrey T Makinson and Henry J McQuay
    Citation: Arthritis Research & Therapy 2005 7:R644

    The Erratum to this article has been published in Arthritis Research & Therapy 2005 8:401

  41. Cardiovascular event rates are markedly increased in rheumatoid arthritis (RA), and RA atherogenesis remains poorly understood. The relative contributions of traditional and nontraditional risk factors to card...

    Authors: Patrick H Dessein, Barry I Joffe and Sham Singh
    Citation: Arthritis Research & Therapy 2005 7:R634
  42. To determine the efficacy and safety of risedronate in patients with knee osteoarthritis (OA), the British study of risedronate in structure and symptoms of knee OA (BRISK), a 1-year prospective, double-blind,...

    Authors: Tim D Spector, Philip G Conaghan, J Christopher Buckland-Wright, Patrick Garnero, Gary A Cline, John F Beary, David J Valent and Joan M Meyer
    Citation: Arthritis Research & Therapy 2005 7:R625

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions